AMES, Iowa, Aug. 14 /PRNewswire-FirstCall/ -- BioForce Nanosciences (OTC Bulletin Board: BFNH) has announced a new brand name for the company's core technology to complement and coincide with the target placement of twenty customer units in 2006. BioForce has placed five units with customers, with another five installations scheduled for the third quarter and is on track to meet its target, the company said. BioForce has developed a benchtop molecular printing system that places tiny domains of biological materials on surfaces with nanometer spatial precision. Previously called the NanoArrayer, it now will be known as the Nano eNabler(TM). "The Nano eNabler brand name is an excellent description of the capabilities our benchtop molecular printing technology provides our customers," said Michael Lynch, product manager. "The feedback we have received from our clients makes this transition to a new brand name an easy decision. Our clients are using the BioForce technology to enable biosensor printing, stem cell studies and tissue engineering, to name a few uses." "This rebranding effort complements our continued plan to develop 20 Nano eNabler customer sites this year," said Kerry Frey, chief operations officer. "I am very pleased that we are on track to meet this placement goal by the end of 2006." "BioForce identifies and qualifies each new technology evaluation site to provide the company with valuable third party feedback on the Nano eNabler performance," said Eric Henderson, founder and chief executive officer. "Information on the value of the Nano eNabler brand for these emerging bionanotechnology applications is important to BioForce as we continue to market our technology." About BioForce Nanosciences, Inc. BioForce Nanosciences is a nanotechnology tools and applications company, providing innovative and practical products that support the growth of the nanotechnology industry. The company has spent more than a decade of invention, research and development on patented and patent-pending nanotechnology products. The core technology is the Nano eNabler(TM) Benchtop Molecular Printer, a portal to new opportunities in nanotechnology. The Nano eNabler opens the door to new and important applications in the biomedical and life sciences markets that lead to improved quality of life. BioForce continues to target inventions that further expand the reach of its proprietary technology and expand its robust patent, trademark and IP portfolio. BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company brings inventions to the marketplace that complement existing innovations, licensing and acquisitions. BioForce is a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH). For more information, visit www.bioforcenano.com. This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the company's most recent filings with the Securities and Exchange Commission. The company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
SOURCE BioForce Nanosciences